Terms: = Uterine cancer AND TRIM27, DASS-46L4_6, RFP, 5987, ENSG00000234495, RNF76 AND Treatment
9404 results:
1. Tailoring postoperative management through sentinel lymph node biopsy in low- and intermediate-risk endometrial cancer - the SENTRY clinical trial.
Sorokin P; Novozhilov M; Utkin D; Abduragimova Z; Dudina I; Nikiforchin A; Kulikova S
Klin Onkol; 2024; 38(2):126-133. PubMed ID: 38697821
[TBL] [Abstract] [Full Text] [Related]
2. Metformin for endometrial hyperplasia.
Shiwani H; Clement NS; Daniels JP; Atiomo W
Cochrane Database Syst Rev; 2024 May; 5():CD012214. PubMed ID: 38695827
[TBL] [Abstract] [Full Text] [Related]
3. Comparison of outcomes between early-stage cervical cancer patients without high-risk factors undergoing adjuvant concurrent chemoradiotherapy and radiotherapy alone after radical surgery.
Zhou Y; Wang W; Tang J; Hu K; Zhang F
BMC Cancer; 2024 Apr; 24(1):548. PubMed ID: 38689248
[TBL] [Abstract] [Full Text] [Related]
4. A Comparative Study of Clinical Outcomes in Locally Advanced Cervical cancer: External Beam Radiotherapy (EBRT) and Sequential High Dose Rate Intracavitary Brachytherapy (HDRICBT) with or without Concurrent Cisplatin on the Day of ICBT Insertion - A Tertiary Care Center Randomized Controlled Trial in India.
Alim S; Siddiqui SA; Akram M; Hakim S; Khan MA
Asian Pac J Cancer Prev; 2024 Apr; 25(4):1333-1338. PubMed ID: 38679994
[TBL] [Abstract] [Full Text] [Related]
5. Epidemiology of uterine cancer in Sarawak, Borneo, A 20-Year Review.
Jawa D; Wong KY; Wahab MB; Azhar A; Foong EJ; Joseph EM; Pangkas J; Ooi CH
Asian Pac J Cancer Prev; 2024 Apr; 25(4):1143-1153. PubMed ID: 38679973
[TBL] [Abstract] [Full Text] [Related]
6. Probing the Effects of Retinoblastoma Binding Protein 6 (RBBP6) Knockdown on the Sensitivity of Cisplatin in Cervical cancer Cells.
Mehta H; Ambele MA; Mokgautsi N; Moela P
Cells; 2024 Apr; 13(8):. PubMed ID: 38667315
[TBL] [Abstract] [Full Text] [Related]
7. Comparing symptom clusters in cancer survivors by cancer diagnosis: A latent class profile analysis.
Lee LJ; Han CJ; Saligan L; Wallen GR
Support Care Cancer; 2024 Apr; 32(5):308. PubMed ID: 38662054
[TBL] [Abstract] [Full Text] [Related]
8. [Establishment of a prognostic nomogram and discussion on optimal treatment for cervical adenocarcinoma:a retrospective study based on SEER database and Chinese single-center data].
Li X; Gao YH; Yang Z; Ma Y; Liu C; Liu GC; Wang DB
Zhonghua Fu Chan Ke Za Zhi; 2024 Apr; 59(4):307-319. PubMed ID: 38644277
[No Abstract] [Full Text] [Related]
9. Sarcoma of the uterine cervix: experience of a single center.
Yuan H; Li L; Li N; Yao H
World J Surg Oncol; 2024 Apr; 22(1):104. PubMed ID: 38637834
[TBL] [Abstract] [Full Text] [Related]
10. Pelvic target volume inter-fractional motion during radiotherapy for cervical cancer with daily iterative cone beam computed tomography.
Zeng Z; Zhu J; Wang Z; Wang G; Yan J; Zhang F
Radiat Oncol; 2024 Apr; 19(1):48. PubMed ID: 38622628
[TBL] [Abstract] [Full Text] [Related]
11. "In our community, we normalize pain": discussions around menstruation and uterine fibroids with Black women and Latinas.
Orellana M; DSouza KN; Yap JQ; Sriganeshan A; Jones ME; Johnson C; Allyse M; Venable S; Stewart EA; Enders F; Balls-Berry JE
BMC Womens Health; 2024 Apr; 24(1):233. PubMed ID: 38610011
[TBL] [Abstract] [Full Text] [Related]
12. Nivolumab with or without ipilimumab in patients with recurrent or metastatic cervical cancer (CheckMate 358): a phase 1-2, open-label, multicohort trial.
Oaknin A; Moore K; Meyer T; López-Picazo González J; Devriese LA; Amin A; Lao CD; Boni V; Sharfman WH; Park JC; Tahara M; Topalian SL; Magallanes M; Molina Alavez A; Khan TA; Copigneaux C; Lee M; Garnett-Benson C; Wang X; Naumann RW
Lancet Oncol; 2024 May; 25(5):588-602. PubMed ID: 38608691
[TBL] [Abstract] [Full Text] [Related]
13. Efficacy and safety of BVAC-C in HPV type 16- or 18-positive cervical carcinoma who failed 1st platinum-based chemotherapy: a phase I/IIa study.
Choi CH; Lee JW; Bae DS; Kang ES; Cho D; Kim YM; Kim K; Kim JW; Kim HS; Kim YT; Lee JY; Lim MC; Oh T; Song B; Jeon I; Park M; Kim WH; Kang CY; Kim BG
Front Immunol; 2024; 15():1371353. PubMed ID: 38605958
[TBL] [Abstract] [Full Text] [Related]
14. Hyperpolarized [1-
Lin G; Hsieh CY; Lai YC; Wang CC; Lin Y; Lu KY; Chai WY; Chen AP; Yen TC; Ng SH; Lai CH
Eur Radiol Exp; 2024 Apr; 8(1):46. PubMed ID: 38594558
[TBL] [Abstract] [Full Text] [Related]
15. A Comparative Study of Deep Learning Dose Prediction Models for Cervical cancer Volumetric Modulated Arc Therapy.
Wu Z; Liu M; Pang Y; Deng L; Yang Y; Wu Y
Technol Cancer Res Treat; 2024; 23():15330338241242654. PubMed ID: 38584413
[No Abstract] [Full Text] [Related]
16. Quality of life improvements in women with uterine fibroids treated with relugolix combination therapy during the LIBERTY long-term extension study: A descriptive subgroup analysis in women with anemia at baseline.
Venturella R; Lukes AS; Wu R; McLean R; Rakov VG; Al-Hendy A
Int J Gynaecol Obstet; 2024 May; 165(2):431-441. PubMed ID: 38576220
[TBL] [Abstract] [Full Text] [Related]
17. Risk of progression of cervical intraepithelial neoplasia grade 2 in human papillomavirus-vaccinated and unvaccinated women: a population-based cohort study.
Krog L; Lycke KD; Kahlert J; Randrup TH; Jensen PT; Rositch AF; Hammer A
Am J Obstet Gynecol; 2024 Apr; 230(4):430.e1-430.e11. PubMed ID: 38569830
[TBL] [Abstract] [Full Text] [Related]
18. Real-world treatment patterns and clinical outcomes from a retrospective chart review study of patients with recurrent or advanced endometrial cancer who progressed following prior systemic therapy in Europe.
Zhang J; Kelkar SS; Prabhu VS; Qiao Y; Grall V; Miles N; Marth C
BMJ Open; 2024 Apr; 14(4):e079447. PubMed ID: 38569701
[TBL] [Abstract] [Full Text] [Related]
19. HPV DNA Testing and Mobile Colposcopy for Cervical Precancer Screening in HIV Positive Women: A Comparison Between Two Settings in Ghana and Recommendation for Screening.
Effah K; Anthony R; Tekpor E; Amuah JE; Wormenor CM; Tay G; Kraa SEY; Katso AM; Akonnor CA; Kemawor S; Danyo S; Atuguba BH; Essel NOM; Akakpo PK
Cancer Control; 2024; 31():10732748241244678. PubMed ID: 38563112
[TBL] [Abstract] [Full Text] [Related]
20. Outcomes of neoadjuvant chemotherapy and radical hysterectomy for locally advanced cervical cancer at Kigali University Teaching Hospital, Rwanda: a retrospective descriptive study.
Ngabonziza E; Ghebre R; DeBoer RJ; Ntasumbumuyange D; Magriples U; George J; Grover S; Bazzett-Matabele L
BMC Womens Health; 2024 Mar; 24(1):204. PubMed ID: 38555423
[TBL] [Abstract] [Full Text] [Related]
[Next]
